Skip to main content
Log in

Österreichische Expertenmeinung zum Standard der Verlaufsbeurteilung von Patienten mit chronischer Polyarthritis (rheumatoider Arthritis)

  • Positionspapier
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Schett G (2006) Arthritis – a nightmare for bone. Wien Klin Wochenschr 118: 11–15

    Article  PubMed  Google Scholar 

  • Wolfe F, Sharp JT (1998) Radiographic outcome of recent-onset rheumatoid arthritis – a 19-year study of radiographic progression. Arthritis Rheum 41: 1571–1582

    Article  CAS  PubMed  Google Scholar 

  • Welsing PMJ, Landewe RBM, van Riel PLCM, Boers M, van Gestel AM, van der Linden S, Swinkels HL, van der Heijde DMFM (2004) The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis – a longitudinal analysis. Arthritis Rheum 50: 2082–2093

    Article  PubMed  Google Scholar 

  • Machold KP, Stamm TA, Nell VPK, Pflugbeil S, Aletaha D, Steiner G, Uffmann M, Smolen JS (2007) Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatol 46: 342–349

    Article  CAS  Google Scholar 

  • Prevoo ML, van Gestel AM, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL (1996) Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score [see comments]. Br J Rheumatol 35: 1101–1105

    Article  CAS  PubMed  Google Scholar 

  • van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41: 1845–1850

    Article  CAS  PubMed  Google Scholar 

  • van Gestel AM, Anderson JJ, van Riel PL, Boers M, Haagsma CJ, Rich B, Wells G, Lange ML, Felson DT (1999) ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol 26: 705–711

    CAS  PubMed  Google Scholar 

  • Felson DT (1993) Choosing a core set of disease activity measures for RA clinical trials. J Rheumatol 20: 531–534

    CAS  PubMed  Google Scholar 

  • Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot jr R, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams HJ, Wolfe F, Kieszak S (1995) American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38: 727–735

    Article  CAS  PubMed  Google Scholar 

  • Aletaha D, Ward MM, Machold KP, Nell VPK, Stamm T, Smolen JS (2005) Remission and active disease in rheumatoid arthritis – defining criteria for disease activity states. Arthritis Rheum 52: 2625–2636

    Article  PubMed  Google Scholar 

  • Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS (2005) Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Research & Therapy 7: R796–R806

    Article  CAS  Google Scholar 

  • Fransen J, Creemers MCW, van Riel PLCM (2004) Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatol 43: 1252–1255

    Article  CAS  Google Scholar 

  • Fransen J, Langenegger T, Michel BA, Stucki G (2000) Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology (Oxford) 39 (3): 321–327

    Article  CAS  Google Scholar 

  • (2008) OMERACT website, accessed on Feb 6, 2008. www.omeract.org

  • Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Kincaid W, Porter D (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364: 263–269

    Article  PubMed  Google Scholar 

  • Goekoop-Ruiterman YPM, Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJSM, Hazes JMW, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, Van Groenendael JHLM, Lems WF, van Krugten MV, Breedveld FC, Dijkmans C (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) – a randomized, controlled trial. Arthritis Rheum 52: 3381–3390

    Article  CAS  PubMed  Google Scholar 

  • Fransen J, Moens HB, Speyer I, van Riel PLCM (2005) Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 64: 1294–1298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fransen J, Stucki G, Twisk J, Chamot AM, Gerster JC, Langenegger T, Seitz M, Michel BA (2003) Effectiveness of a measurement feedback system on outcome in rheumatoid arthritis: a controlled clinical trial. Ann Rheum Dis 62: 624–629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Machold KP, Nell VP, Aletaha D, Smolen JS, Stamm TA (2006) Activity-score based therapy in rheumatoid arthritis. Z Rheumatol 65: 124–130

    Article  CAS  PubMed  Google Scholar 

  • Simms RW, Kwoh CK, Anderson LG, Erlandson DM, Greene JM, Kelleher M, Odell JR, Partridge AJ, Roberts WN, Robbins ML, Yood RA, Liang MH (1996) Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 39: 723–731

    Article  Google Scholar 

  • Pham T, Gossec L, Fautrel B, Combe B, Flipo RM, Goupille P, Le Loet X, Mariette X, Puechal X, Wendling D, Schaeverbeke T, Sibilia J, Sany J, Dougados M (2005) Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine 72: 222–228

    Article  PubMed  Google Scholar 

  • Konsensusstatement der ÖGR für den Arzt zur Basistherapie chronischen Polyarthritis und anderen entzündlich rheumatischen Gelenkserkrankungen (2006).www.rheumatologie.at/publikationen/leitlinien.php

  • Gossec L, Fautrel B, Pham T, Combe B, Flipo RM, Goupille P, Le Loet X, Mariette X, Puechal X, Wendling D, Schaeverbeke T, Sibilia J, Sany J, Dougados M (2005) Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine 72: 229–234

    Article  PubMed  Google Scholar 

  • Aletaha D, Smolen JS (2002) Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis. Arthritis Rheum 47: 181–188

    Article  PubMed  Google Scholar 

  • van der Heijde DM, van't Hof M, van Riel PL, van de Putte LB (1993) Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20: 579–581

    CAS  PubMed  Google Scholar 

  • Leeb BF, Haindl PM, Maktari A, Nothnagl T, Rintelen B (2007) DAS28 values differ considerably depending on patient's pain perception and gender. J Rheumatol 34: 2382–2387

    CAS  PubMed  Google Scholar 

  • Leeb BF, Sautner J, Leeb BA, Fassl C, Rintelen B (2006) Lack of agreement between patients' and physicians' perspectives of rheumatoid arthritis disease activity changes. Scandinavian J Rheumatol 35: 441–446

    Article  CAS  Google Scholar 

  • Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R, and The European Leflunomide Study Group (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomized, multicentre trial. Lancet 353: 259–265

    Article  CAS  PubMed  Google Scholar 

  • Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340: 253–259

    Article  CAS  PubMed  Google Scholar 

  • Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 354: 1932–1939

    Article  CAS  PubMed  Google Scholar 

  • Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK (2003) Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate – The ARMADA trial. Arthritis Rheum 48: 35–45

    Article  CAS  PubMed  Google Scholar 

  • Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312: 818–822

    Article  CAS  PubMed  Google Scholar 

  • Leeb BF, Andel I, Sautner J, Nothnagl T, Rintelen B (2004) The DAS28 in rheumatoid arthritis and fibromyalgia patients. Rheumatol 43: 1504–1507

    Article  CAS  Google Scholar 

  • Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F (1993) The American College of Rheumatology Preliminary Core Set of Disease-Activity Measures for Rheumatoid-Arthritis Clinical-Trials. Arthritis Rheum 36: 729–740

    Article  CAS  PubMed  Google Scholar 

  • Fries JP, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23: 137–145

    Article  CAS  PubMed  Google Scholar 

  • Meenan RF, Gertman PM, Mason JH, Dunaif R (1982) The arthritis impact measurement scales. Further investigations of a health status measure. Arthritis Rheum 25: 1048–1053

    Article  CAS  PubMed  Google Scholar 

  • Meenan RF, Gertman PM, Mason JH (1980) Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum 23: 146–152

    Article  CAS  PubMed  Google Scholar 

  • (2007) Euroqol website. www.euroqol.org, accessed on 6.8.2007

  • Ware JE, Sherbourne CD (1992) The Mos 36-Item Short-Form Health Survey (Sf-36). 1. Conceptual framework and item selection. Medical Care 30: 473–483

    Article  PubMed  Google Scholar 

  • Mchorney CA, Ware JE, Raczek AE (1993) The Mos 36-Item Short-Form Health Survey (Sf-36). 2. Psychometric and clinical tests of validity in measuring physical and mental-health constructs. Medical Care 31: 247–263

    Article  CAS  PubMed  Google Scholar 

  • Mchorney CA, Ware JE, Lu JFR, Sherbourne CD (1994) The Mos 36-Item Short-Form Health Survey (Sf-36). 3. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care 32: 40–66

    Article  CAS  PubMed  Google Scholar 

  • Leeb BF, Andel I, Leder S, Leeb BA, Rintelen B (2005) The patient's perspective and rheumatoid arthritis disease activity indexes. Rheumatol 44: 360–365

    Article  CAS  Google Scholar 

  • Aletaha D, Smolen J, Ward MM (2006) Measuring function in rheumatoid arthritis – identifying reversible and irreversible components. Arthritis Rheum 54: 2784–2792

    Article  PubMed  Google Scholar 

  • Aletaha D, Strand V, Smolen JS, Ward MM (2007) Treatment-related improvement in physical function varies with duration of rheumatoid arthritis. A pooled analysis of clinical trial results. Annals of the Rheumatic Diseases 10.1136/ard.2007.071415 (epub ahead of print)

  • Pincus T (2007) Patient questionnaires and formal education as more significant prognostic markers than radiographs or laboratory tests for rheumatoid arthritis mortality – limitations of a biomedical model to predict long-term outcomes. Bull NYU Hosp Jt Dis 65 [Suppl 1]: S29–S36

    PubMed  Google Scholar 

  • Soderlin MK, Nieminen P, Hakala M (1998) Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol 25: 1895–1899

    CAS  PubMed  Google Scholar 

  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TAJ, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of Rheumatoid Arthritis. Arthritis Rheum 31: 315–324

    Article  CAS  PubMed  Google Scholar 

  • van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, te Meerman GJ, van Riel PLCM, Houtman PM, van de Putte LBA, Limburg PC (1993) The acute phase response in relation to radiographic progression of early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 32 [Suppl 3]: 9–13

    Article  PubMed  Google Scholar 

  • Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS (1993) Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. Br J Rheumatol 32: 199–203

    Article  CAS  PubMed  Google Scholar 

  • Munoz-Fernandez S, Alvarez-Doforno R, Cuesta M, Balsa A, Fontan G, Gijon-Banos J (1995) Antiperinuclear factor: a useful test for the diagnosis of rheumatoid arthritis. Rheumatol Int 15: 145–149

    Article  CAS  PubMed  Google Scholar 

  • Steiner G, Skriner K, Smolen JS (1996) Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleo-protein complex: novel tools for the diagnosis of rheumatic diseases. Int Arch Allergy Immunol 111: 314–319

    Article  CAS  PubMed  Google Scholar 

  • van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JM (1998) Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 37: 1084–1088

    Article  CAS  PubMed  Google Scholar 

  • Cordonnier C, Meyer O, Palazzo E, de Bandt M, Elias A, Nicaise P, Haim T, Kahn MF, Chatellier G (1996) Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis. Br J Rheumatol 35: 620–624

    Article  CAS  PubMed  Google Scholar 

  • Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46: 357–365

    Article  PubMed  Google Scholar 

  • Garnero P, Geusens P, Landewe R (2003) Biochemical markers of joint tissue turnover in early rheumatoid arthritis. Clin Exp Rheumatol 21: S54–S58

    CAS  PubMed  Google Scholar 

  • Hueber W, Utz PJ, Robinson WH (2003) Autoantibodies in early arthritis: advances in diagnosis and prognostication. Clin Exp Rheumatol 21: S59–S64

    CAS  PubMed  Google Scholar 

  • Dorner T, Egerer K, Feist E, Burmester GR (2004) Rheumatoid factor revisited. Curr Opin Rheumatol 16: 246–253

    Article  CAS  PubMed  Google Scholar 

  • Goldbach-Mansky R, Lee J, Mccoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Menard HA, Zhou ZJ, Palosuo T, van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR, El Gabalawy HS (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Research 2: 236–243

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nell VPK, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64: 1731–1736

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kroot EJJA, de Jong BAW, van Leeuwen MA, Swinkels H, van den Hoogen FHJ, van't Hof M, van de Putte LBA, van Rijswijk MH, van Venrooij WJ, van Riel PLCM (2000) The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43: 1831–1835

    Article  CAS  PubMed  Google Scholar 

  • Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M (2006) Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Research Therapy 8: R119

    Article  PubMed  PubMed Central  Google Scholar 

  • Herold M, Boeser V, Russe E, Klotz W (2005) Anti-CCP: history and its usefulness. Clin Dev Immunol 12: 131–135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • van der Helm-van Mil, le Cessie S, Van Dongen H, Breedveld FC, Toes REM, Huizinga TWJ (2007) A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis – how to guide individual treatment decisions. Arthritis Rheum 56: 433–440

    Article  Google Scholar 

  • Quinn MA, Green MJ, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ, Conaghan PG, Emery P (2003) Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 48: 3039–3045

    Article  PubMed  Google Scholar 

  • van Gaalen FA, van Aken J, Huizinga TWJ, Schreuder GMT, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes REM, de Vries RRP (2004) Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 50: 2113–2121

    Article  CAS  PubMed  Google Scholar 

  • Huizinga TWJ, Amos CI, van der Helm-van Mil, Chen W, van Gaalen FA, Jawaheer D, Schreuder GMT, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RRP, Gregersen PK, Toes REM, Criswell LA (2005) Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 52: 3433–3438

    Article  CAS  PubMed  Google Scholar 

  • Dawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF (1986) Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 25: 44–49

    Article  CAS  PubMed  Google Scholar 

  • Choy EH, Scott DL (1995) Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies. Drugs 50 [Suppl 1]: 15–25

    Article  PubMed  Google Scholar 

  • van der Heijde DM, van Riel PL, van Leeuwen MA, van't Hof MA, van Rijswijk MH, van de Putte LB (1992) Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 31: 519–525

    Article  CAS  PubMed  Google Scholar 

  • Simon CH, Vlieland TPMV, Dijkmans BAC, Moens HJB, Janssen M, Hazes JMW, Franken HCM, Vandenbroucke JP, Breedveld FC (1998) Laboratory screening for side effects of disease modifying antirheumatic drugs in daily rheumatological practice. Scand J Rheumatol 27: 170–179

    Article  CAS  PubMed  Google Scholar 

  • Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC) (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161 (4 Pt 2): S221–S247

    Google Scholar 

  • Ormerod LP, Milburn HJ, Gillespie S, Ledingham J, Rampton D (2005) BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 60: 800–805

    Article  Google Scholar 

  • Schaberg T, Hauer B, Haas WH, Hohlfeld J, Kropp R, Loddenkemper R, Loytved G, Magdorf K, Rieder HL, Sagebiel D (2004) Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany. Pneumologie 58: 255–270

    Article  CAS  PubMed  Google Scholar 

  • Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn G, Kane D, O'Connor PJ, Manger B, Joshua F, Koski J, Grassi W, Lassere MND, Swen N, Kainberger F, Klauser A, Ostergaard M, Brown AK, Machold KP, Conaghan PG (2005) Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 32: 2485–2487

    PubMed  Google Scholar 

  • Ostergaard M, Ejbjerg B, Szkudlarek M (2005) Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Best Practice & Research in Clinical Rheumatology 19: 91–116

    Article  Google Scholar 

  • Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, Shnier R, O'Connor P, Klarlund M, Emery P, Genant H, Lassere M, Edmonds J (2003) OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 30: 1385–1386

    PubMed  Google Scholar 

  • Ejbjerg BJ, Vestergaard A, Jacobsen S, Thomsen HS, Ostergaard M (2005) The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints – a comparison of the OMERACT rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp/van der Heijde radiographic score. Arthritis Rheum 52: 2300–2306

    Article  PubMed  Google Scholar 

  • Kainberger F, Peloschek P, Friedrich K, Pinker K, Redlich K, Schett G (2002) Magnetic resonance imaging (MRI) in early diagnosis and follow-up of rheumatoid arthritis. Aktuelle Rheumatologie 27: 311–316

    Article  Google Scholar 

  • Uffmann M, Schaefer-Prokop C, Neitzel U, Weber M, Herold CJ, Prokop M (2004) Skeletal applications for flat-panel versus storage-phosphor radiography: effect of exposure on detection of low-contrast details. Radiology 231: 506–514

    Article  PubMed  Google Scholar 

  • Ludwig K, Henschel A, Bernhardt TM, Lenzen H, Wormanns D, Diederich S, Heindel W (2003) Performance of a flat-panel detector in the detection of artificial erosive changes: comparison with conventional screen-film and storage-phosphor radiography. Eur Radiol 13: 1316–1323

    PubMed  Google Scholar 

  • Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagnos 18: 481–491

    Article  CAS  Google Scholar 

  • Sharp JT (1996) Scoring radiographic abnormalities in rheumatoid arthritis. Radiol Clin N Am 34: 233–241

    CAS  PubMed  Google Scholar 

  • Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A (1998) A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 25: 2094–2107

    CAS  PubMed  Google Scholar 

  • Bruynesteyn K, van der Heijde D, Boers M, Saudan A, Peloso P, Paulus H, Houben H, Griffiths B, Edmonds J, Bresnihan B, Boonen A, van der Linden S (2002) Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence. J Rheumatol 29: 2306–2312

    PubMed  Google Scholar 

  • Bruynesteyn K, van der Heijde D, Boers M, Lassere M, Boonen A, Edmonds J, Houben H, Paulus H, Peloso P, Saudan A, van der Linden S (2001) Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts. J Rheumatol 28: 904–910

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Klaus P. Machold.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Machold, K., Brezinsek, H., Leeb, B. et al. Österreichische Expertenmeinung zum Standard der Verlaufsbeurteilung von Patienten mit chronischer Polyarthritis (rheumatoider Arthritis). Wien Klin Wochenschr 120, 234–241 (2008). https://doi.org/10.1007/s00508-008-0958-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-008-0958-9

Navigation